Overview

A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic

Status:
Recruiting
Trial end date:
2020-12-27
Target enrollment:
Participant gender:
Summary
Prophylactic treatment in cancer patients undergoing antineoplastic therapy during the COVID-19 pandemic.
Phase:
Phase 2
Details
Lead Sponsor:
Prof. Dr. Matthias Preusser
Treatments:
Azithromycin